Intravesical cascade delivery of active monoterpene coumarin for bladder cancer therapy-Reference-Cited by-同舟云学术

Intravesical cascade delivery of active monoterpene coumarin for bladder cancer therapy

Published:2024 Issue:17 Volume:5 Page:6910-6924
ISSN:2633-5409
Container-title:Materials Advances
language:en
Short-container-title:Mater. Adv.

Author:

Lai Yanwei¹,Deng Dashi¹²,Yuan Simin²,Liu Xiaocen³,Lei Qifang³,Li Guangzhi¹²^ORCID

Affiliation:

1. Luohu Clinical College of Shantou University Medical College, Shantou University Medical College, Shantou, 515000 Guangdong, China

2. Institute of Urology, The Affiliated Luohu Hospital of Shenzhen University, Shenzhen University, Shenzhen 518000, China

3. Institute of Urology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen 518116, China

Abstract

Albumin nanocarriers encapsulate the active monoterpene coumarin UM-15 and assemble with fluorinated chitosan (FCS) to form UM-15@BSA/FCS nanoparticles.

Funder

National Natural Science Foundation of China

Guangdong Medical Research Foundation

Natural Science Foundation of Guangdong Province

Basic and Applied Basic Research Foundation of Guangdong Province

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MA/D4MA00528G

Reference40 articles.

1. The global burden of urinary bladder cancer: an update

2. ATG7 Promotes Bladder Cancer Invasion via Autophagy‐Mediated Increased ARHGDIB mRNA Stability

3. Metabolic Modulation of Intracellular Ammonia via Intravesical Instillation of Nanoporter‐Encased Hydrogel Eradicates Bladder Carcinoma

4. Improving Guideline Adherence in Urology

5. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines